CDC Grant for National Partnerships to Address Prenatal Substance Use and Fetal Alcohol Spectrum Disorders

In the “Descriptive Title of Applicant’s Project” on the SF-424 form, applicants must identify the component to which they are applying.

CDC proposes to allocate funds to implement Notice of Funding Opportunity (NOFO) DD22-2201, Addressing Fetal Alcohol Spectrum Disorders through National Partnerships. The project period will be four years, with 4 12-month budget periods and an anticipated project start date of September 30, 2022. The purpose of this NOFO is to promote the prevention of FASDs and the early identification and management of infants and children with FASDs through a collaborative framework of national partner organizations. Strategic areas of focus may include training clinical, public health, or community-based organizations serving populations of reproductive age, including pregnant people, as well as those serving children and families about prenatal alcohol and other substance use, screening and brief intervention for alcohol and other substances, and identification and management of children living with FASDs; developing and disseminating evidence-based recommendations and messaging nationally, regionally, and through health systems and other networks to prevent or reduce alcohol and other substance use among people who are pregnant or might be pregnant as well as to promote early identification and management of children living with FASDs; developing and fostering or participating in a champions network to galvanize support for and share messaging and resources about prevention of FASDs and early identification and management of children living with FASDs; building community, state, and local capacity to link clinical and public health partners to reach affected populations with effective programs and practices; coordinating efforts across projects to ensure consistent information and resources are being used; and evaluating the effectiveness of program strategies.